IL196038A0 - Cyanocobalamin low viscosity aqueous formulations for intranasal delivery - Google Patents

Cyanocobalamin low viscosity aqueous formulations for intranasal delivery

Info

Publication number
IL196038A0
IL196038A0 IL196038A IL19603808A IL196038A0 IL 196038 A0 IL196038 A0 IL 196038A0 IL 196038 A IL196038 A IL 196038A IL 19603808 A IL19603808 A IL 19603808A IL 196038 A0 IL196038 A0 IL 196038A0
Authority
IL
Israel
Prior art keywords
cyanocobalamin
low viscosity
aqueous formulations
intranasal delivery
viscosity aqueous
Prior art date
Application number
IL196038A
Other versions
IL196038A (en
Original Assignee
Qol Medical Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qol Medical Llc filed Critical Qol Medical Llc
Publication of IL196038A0 publication Critical patent/IL196038A0/en
Publication of IL196038A publication Critical patent/IL196038A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL196038A 2006-06-23 2008-12-18 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery IL196038A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/024685 WO2007149098A1 (en) 2006-06-23 2006-06-23 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery

Publications (2)

Publication Number Publication Date
IL196038A0 true IL196038A0 (en) 2009-09-01
IL196038A IL196038A (en) 2016-10-31

Family

ID=38833714

Family Applications (2)

Application Number Title Priority Date Filing Date
IL196038A IL196038A (en) 2006-06-23 2008-12-18 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
IL248447A IL248447B (en) 2006-06-23 2016-10-21 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL248447A IL248447B (en) 2006-06-23 2016-10-21 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery

Country Status (10)

Country Link
EP (1) EP2035441A4 (en)
JP (1) JP5769924B2 (en)
KR (3) KR20170098977A (en)
CN (1) CN101600729A (en)
AU (1) AU2006344733B2 (en)
CA (1) CA2656823C (en)
IL (2) IL196038A (en)
NO (1) NO20090368L (en)
WO (1) WO2007149098A1 (en)
ZA (1) ZA200900191B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA024475B1 (en) * 2010-10-29 2016-09-30 Троикаа Фармасьютикалз Лимитед Intranasal compositions of vitamin b12
CN110603033A (en) * 2017-03-02 2019-12-20 荷兰可再生能源公司 Intranasal administration of physiologically active substances
US20220111162A1 (en) * 2020-07-29 2022-04-14 Lido Ventures Llc Apparatus, system, and method for facilitating intranasal treatment of a patient

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE70180T1 (en) * 1985-04-16 1991-12-15 Nastech Pharm Co AEROSOL FOR NOSE DUSTING OF VITAMIN B 12.
US4724231A (en) * 1985-04-16 1988-02-09 Nastech Pharmaceutical, Inc. Nasel compositions containing vitamin B12
US5112804A (en) * 1987-04-01 1992-05-12 Temple University Of The Commonwealth System Of Higher Education Pharmaceutical composition and method of intranasal administration
US4959176A (en) * 1988-04-29 1990-09-25 Beckman Instruments, Inc. High resolution non corrosive amino acid analysis buffer solutions
US5227311A (en) * 1988-10-11 1993-07-13 Abbott Laboratories Intrinsic factor to determine B12
BE1007839A6 (en) * 1993-12-20 1995-10-31 Merkus Franciscus W H M Prof PHARMACEUTICAL COMPOSITION FOR THE NASAL ADMINISTRATION OF HYDROXOCOBALAMINE.
US6406730B1 (en) * 1998-12-01 2002-06-18 Carl E. Banyard Process for producing low acid food products
FR2787029A1 (en) * 1998-12-09 2000-06-16 Biovector Therapeutics USE IN A PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION OF VITAMIN B12 FOR THE DELIVERY OF ACTIVE AGENTS TO THE CENTRAL NERVOUS SYSTEM
CN1461210A (en) * 2000-09-20 2003-12-10 尼库麦德制药As Preparation of vitamin emulsions and concentrates thereof
US20060074034A1 (en) * 2001-09-17 2006-04-06 Collins Douglas A Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof
US6911434B2 (en) * 2002-02-04 2005-06-28 Corixa Corporation Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
DE10300719A1 (en) * 2003-01-11 2004-07-22 Basf Ag Improved process for the production of vitamin B12
US20060127320A1 (en) * 2004-05-10 2006-06-15 Nastech Pharmaceutical Company Inc. Method of delivering parathyroid hormone to a human
US20060046969A1 (en) * 2004-08-25 2006-03-02 Aegis Therapeutics Llc Antibacterial compositions for drug administration
JP2009504767A (en) * 2005-08-17 2009-02-05 フレミング・アンド・カンパニー・ファーマシューティカルズ Vitamin B12 nasal spray and method of use

Also Published As

Publication number Publication date
AU2006344733B2 (en) 2014-02-27
JP2009541312A (en) 2009-11-26
EP2035441A1 (en) 2009-03-18
EP2035441A4 (en) 2013-01-16
IL248447A0 (en) 2016-11-30
JP5769924B2 (en) 2015-08-26
AU2006344733A1 (en) 2007-12-27
NO20090368L (en) 2009-03-23
IL196038A (en) 2016-10-31
CA2656823C (en) 2015-02-03
CN101600729A (en) 2009-12-09
CA2656823A1 (en) 2007-12-27
KR20090074722A (en) 2009-07-07
KR20140101010A (en) 2014-08-18
WO2007149098A1 (en) 2007-12-27
KR20170098977A (en) 2017-08-30
ZA200900191B (en) 2012-09-26
IL248447B (en) 2021-10-31

Similar Documents

Publication Publication Date Title
GB2444395B (en) Delivery devices
GB2444394B (en) Delivery devices
GB0611312D0 (en) Intranasal administration
EP2046290A4 (en) Aqueous dronabinol formulations
GB0704302D0 (en) Nasal delivery
GB0705625D0 (en) Nasal delivery
GB0704278D0 (en) Nasal delivery
IL195224A0 (en) Delivery method
GB0819507D0 (en) Aqueous primer composition
EP2075138A4 (en) Aqueous coating agent
EP2105459A4 (en) Aqueous solution composition
EP1994933A4 (en) Aqueous composition
EP2172224A4 (en) Aqueous composition
IL248447A0 (en) Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
SI2054455T1 (en) Stable aqueous novolac dispersion
GB2435420B (en) Delivery means
GB0711440D0 (en) Aqueous formulations
GB0709390D0 (en) Delivery means
GB2476731B (en) Delivery devices
EP2000489A4 (en) Curable aqueous composition
EP1972040A4 (en) Terminal adapter
GB0803235D0 (en) Aqueous formulations
GB0616952D0 (en) Delivery
GB2461433B (en) Delivery devices
IL190566A0 (en) Compositions for intranasal delivery

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed